Techcyte

Summary active Updated Apr 30, 2026

This profile is AI-generated. If you spot an error, please help us fix it by sharing a URL to the correct information.

Location Orem, UT
Founded 2013
Latest Stage Growth
Total Raised $50M+
Website https://techcyte.com
Sector
healthtech digital-health ai medical-imaging diagnostics veterinary pathology

Founders

Ben Cahoon CEO

About

Techcyte is an AI-powered digital diagnostics platform for anatomic and clinical pathology, headquartered in Orem, Utah 1. The company’s Fusion platform integrates AI, digitized workflows, and laboratory system interoperability across human, veterinary, and environmental pathology segments 1 2. Techcyte’s veterinary business is currently profitable, and the company expects its environmental and human segments to reach profitability within the next year 1.

The 2026 round includes access to 17 million de-identified Mayo Clinic slides as a training dataset to improve Techcyte’s AI diagnostic accuracy 2.

Funding History

Date Round Amount Lead Co-investors
2026-04-30 Growth $15M Van Tuyl Companies Zoetis, Mayo Clinic 1 2 3

Canaccord Genuity LLC served as exclusive advisor to Techcyte on the 2026 transaction 1.

What Investors Say

No independently sourced investor quotes from this round found at time of profile.

What Founders Say

Ben Cahoon, CEO of Techcyte, on the company’s product strategy: “Laboratories are being asked to do more with less, while maintaining high standards for quality and rapid turnaround times. Techcyte Fusion® directly addresses these challenges through unified AI-enabled pathology workflows.” 1

Sources

  1. Business Wire / Yahoo Finance, “Techcyte Announces $15 Million Capital Raise Led by Van Tuyl Companies to Support Growth and Path to Profitability,” April 30, 2026, accessed April 2026. https://finance.yahoo.com/sectors/healthcare/articles/techcyte-announces-15-million-capital-210000240.html↩↩↩↩↩↩

  2. FinSMEs, “Techcyte Raises $15M in Funding,” May 2026, accessed April 2026. https://www.finsmes.com/2026/05/techcyte-raises-15m-in-funding.html↩↩↩

  3. Pulse 2.0, “Techcyte: $15 Million Raised To Scale AI-Powered Digital Pathology Platform Toward Profitability,” accessed April 2026. https://pulse2.com/techcyte-15-million-raised-to-scale-ai-powered-digital-pathology-platform-toward-profitability/↩